AGT and cardiac hypertrophy: The overexpression of Nrf2 inhibits cardiomyopathy and ROS produced by Ang II administration, whereas the absence of Nrf2 exacerbates cardiac hypertrophy, inflammation, fibrosis and oxidative stress in cultured cardiomyocytes and Nrf2‐deficient mice.23, 25